SUGAMMADEX INJECTION
SUGAMMADEX INJECTION
Approved
DIN Number
02548666
Drug Class
Human
Market Date
Jun 16, 2025
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02548666
AIG Number0157810001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AB35 SUGAMMADEX
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification91:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
SUGAMMADEX (SUGAMMADEX SODIUM)Active
Strength: 100 MG / ML
Monograph: SUGAMMADEX (SUGAMMADEX SODIUM)